D-Glutamate

D-Glutamate

SCHEMBL457311

NC(CCC(=O)O)C(=O)O.O=C(O)CCCC(=O)C(=O)O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 2/20 0.69
GRM6 O15303 2/20 0.69
GRM7 Q14831 2/20 0.69
GRM4 Q14833 2/20 0.69
GSR P00390 2/20 0.69
GRIN2D O15399 1/20 0.69
GRIN3B O60391 1/20 0.69
CYP1A2 P05177 1/20 0.69
GRIK1 P39086 1/20 0.69
GRM5 P41594 1/20 0.69
GRIA1 P42261 1/20 0.69
GRIA2 P42262 1/20 0.69
GRIA3 P42263 1/20 0.69
SLC1A3 P43003 1/20 0.69
SLC1A2 P43004 1/20 0.69
SLC1A1 P43005 1/20 0.69
GRIA4 P48058 1/20 0.69
GRIN1 Q05586 1/20 0.69
GRIN2A Q12879 1/20 0.69
GRIK2 Q13002 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Glutamic Acid SCHEMBL457312 1.00 GRM8 (0.69) GRM8GRM6GRM7GRM4GSR
(S)-2-Aminoadipic Acid SCHEMBL29106852 0.92 GSR (0.57) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL5076309 0.90 GSR (0.86) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL5076310 0.90 GSR (0.86) GRM8GRM6GRM7GRM4GSR
(S)-2-Aminoadipic Acid SCHEMBL29106848 0.89 GSR (0.53) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL148727 0.88 GRM8 (0.75) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL148726 0.88 GRM8 (0.75) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL6138602 0.88 GRM8 (0.75) GRM8GRM6GRM7GRM4GSR
Lysine SCHEMBL2020671 0.86 GSR (0.67) GRM8GRM6GRM7GRM4GSR
Lysine SCHEMBL2020669 0.86 GSR (0.67) GRM8GRM6GRM7GRM4GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190091300-A1 METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2019-03-28 US disclosed
US-10159717-B2 Methods of treating cancer of the central nervous system YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2018-12-25 US disclosed
US-20150216949-A1 METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2015-08-06 US disclosed
US-9034319-B2 Methods of treating cancer of the central nervous system YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2015-05-19 US disclosed
US-20120231512-A1 PREPARATION OF ALPHA-KETOPIMELIC ACID DSM IP ASSETS B.V. (NL) 2012-09-13 US disclosed
US-20120156737-A1 PREPARATION OF ALPHA-KETOPIMELIC ACID DSM IP ASSETS B.V. (NL) 2012-06-21 US disclosed
WO-2012031911-A2 PREPARATION OF 6-AMINOCAPROIC ACID FROM ALPHA-KETOPIMELIC ACID DSM IP ASSETS B.V. (NL) 2012-03-15 WO disclosed
EP-2406384-A2 PREPARATION OF ALPHA-KETOPIMELIC ACID DSM IP Assets B.V. (NL) 2012-01-18 EP disclosed
US-20110070218-A1 METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2011-03-24 US disclosed
WO-2011031147-A1 PREPARATION OF A COMPOUND COMPRISING AN AMINE GROUP FROM AN ALPHA-KETO ACID DSM IP ASSETS B.V. (NL) 2011-03-17 WO disclosed
WO-2011031146-A2 PREPARATION OF ALPHA-KETOPIMELIC ACID DSM IP ASSETS B.V. (NL) 2011-03-17 WO disclosed
WO-2010104390-A2 PREPARATION OF ALPHA-KETOPIMELIC ACID DSM IP ASSETS B.V. (NL) 2010-09-16 WO disclosed
US-7767204-B2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2010-08-03 US disclosed
US-20090304661-A1 Method And Composition For Proctecting Neuronal Tissue From Damage Induced By Elevated Glutamate Levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. AT THE WEIZMANN INSTITUTE OF SCEINCE (IL) 2009-12-10 US disclosed
US-20080233096-A1 transaminase, dehydrogenase, decarboxylase, ligase as glutamate modifying enzymes and oxaloacetate, pyruvate, NAD+, NADP+, 2-oxohexanedioic acid, 2-oxo-3-sulfopropionate, 2-oxo-3-sulfinopropionic acid, 2-oxo-3-phenylpropionic acid co-factors to enhance brain to blood efflux YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-09-25 US disclosed
US-20080233099-A1 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-09-25 US disclosed
US-7404951-B2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2008-07-29 US disclosed
US-20060024284-A1 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2006-02-02 US disclosed